The Africa Centres for Disease Control and Prevention (Africa CDC) has launched the African Manufacturing Market Intelligence and Network Analysis (AMMINA) platform — a data-driven initiative aimed at strengthening Africa’s health products manufacturing ecosystem and promoting regional health sovereignty.
The launch took place on Saturday during the African Healthcare Manufacturing Trade Exhibition and Conference (AHMTEC) in Accra, Ghana, and was held virtually via webinar.
According to the Africa CDC, the AMMINA platform is designed to provide comprehensive and actionable insights into Africa’s health manufacturing landscape. It captures critical data on manufacturers, production capacities, product portfolios, and market dynamics across the continent.
Developed under the custodianship of the Africa CDC, and building on an initial curation by the Bill & Melinda Gates Foundation, the initiative reinforces the Centre’s commitment to advancing local production, innovation, and investment within Africa’s health sector.
Africa CDC Director-General, Dr. Jean Kaseya, described the platform as a landmark achievement that will enhance evidence-based decision-making and strategic collaboration across the continent.
“We are pleased to launch this landmark initiative. AMMINA represents a bold step towards making high-quality, reliable, and accessible data available to our member states and partners,” Kaseya said.
“Africa CDC is committed to ensuring that AMMINA becomes a trusted continental resource to advance health products manufacturing, investment, and policy decision-making across Africa.”
Kaseya noted that, in its initial phase, AMMINA maps data from more than 700 manufacturers and 2,500 health products across 18 African Union (AU) member states. The Africa CDC, in collaboration with partners, plans to expand this coverage to all 55 AU member states — positioning the platform as a continental public good under the AU framework.
He added that the platform is expected to serve as a catalyst for intra-African trade, attract investment, and foster industrial growth in health products manufacturing.
According to him, AMMINA is one of the key drivers for achieving the AU’s goal of reducing dependency on imported medical products and securing Africa’s health future.
The initiative will also enhance coordination among AU institutions, member states, and private sector stakeholders to unlock Africa’s full manufacturing potential and ensure sustainable access to essential health products.
Africa’s health manufacturing landscape is undergoing transformation, driven by efforts toward self-reliance, innovation, and regional collaboration. Countries such as Morocco and Rwanda have already made notable progress with advanced manufacturing facilities, supported by initiatives like the African Vaccine Manufacturing Accelerator (AVMA) — which aims to meet 60% of the continent’s vaccine needs by 2040.
Despite these gains, challenges remain, including limited end-to-end manufacturing, supply chain disruptions, energy constraints, and significant skills shortages.
The Africa CDC says AMMINA will help address these gaps by providing actionable intelligence to guide investment, policy, and partnership decisions. Key initiatives will include building Regional Capability and Capacity Networks (RCCNs) to develop workforce skills and enhance research.
The platform, the agency added, will also focus on sustained investment, infrastructure development, and regional collaboration — critical pillars for achieving Africa’s long-term goal of health sovereignty.
